Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010-2012

Veterinary Microbiology

Volumn 169, Issue 3-4, 2014, Pages 113-127

  Woodward, Alana L ^a   Rash, Adam S ^a   Blinman, Donna ^a   Bowman, Samantha ^a   Chambers, Thomas M ^b   Daly, Janet M ^c   Damiani, Armando ^d   Joseph, Sunitha ^e   Lewis, Nicola ^f   McCauley, John W ^g   Medcalf, Liz ^a   Mumford, Jenny ^f   Newton, J Richard ^a   Tiwari, Ashish ^b   Bryant, Neil A ^a   Elton, Debra M ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e CENTRAL VETERINARY RESEARCH LABORATORY   (United Arab Emirates)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Antigenic cartography; Equine influenza virus; H3N8; Neuraminidase; Surveillance

Indexed keywords

ANTIGENIC CARTOGRAPHY; EQUINE INFLUENZA VIRUS; H3N8; NEURAMINIDASE; SURVEILLANCE;

AMINO ACID SEQUENCE; ANIMALS; EUROPE; HEMAGGLUTININS, VIRAL; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; POPULATION SURVEILLANCE; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; UNITED ARAB EMIRATES; UNITED STATES;

EID: 84894250800     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.11.039     Document Type: Article

References (38)

1. Brett I.C., Johansson B.E. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 2005, 339:273-280.
2. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., MacRae S., Lewis N.S., Paillot R., Zanoni R., Meier H., Griffiths L.A., Daly J.M., Tiwari A., Chambers T.M., Newton J.R., Elton D.M. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 2009, 138:41-52.
3. Bryant N.A., Paillot R., Rash A.S., Medcalf E., Montesso F., Ross J., Watson J., Jeggo M., Lewis N.S., Newton J.R., Elton D.M. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak. Vet. Res. 2010, 41:19.
4. Bryant N.A., Rash A.S., Woodward A.L., Medcalf E., Helwegen M., Wohlfender F., Cruz F., Herrmann C., Borchers K., Tiwari A., Chambers T.M., Newton J.R., Mumford J.A., Elton D.M. Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet. Microbiol. 2011, 147:19-27.
5. Callinan I. Equine Influenza: The August 2007 Outbreak in Australia 2008, Commonwealth of Australia, www.equineinfluenzainquiery.gov.au.
6. Cook R.F., Sinclair R., Mumford J.A. Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses. J. Virol. Methods 1988, 20:1-12.
7. Daly J.M., Lai A.C., Binns M.M., Chambers T.M., Barrandeguy M., Mumford J.A. Antigenic and genetic evolution of equine H3N8 influenza A viruses. J. Gen. Virol. 1996, 77:661-671.
8. Damiani A.M., Scicluna M.T., Ciabatti I., Cardeti G., Sala M., Vulcano G., Cordioli P., Martella V., Amaddeo D., Autorino G.L. Genetic characterization of equine influenza viruses isolated in Italy between 1999 and 2005. Virus Res. 2008, 131:100-105.
9. Gagnon C.A., Elahi S.M., Tremblay D., Lavoie J.P., Bryant N.A., Elton D.M., Carman S., Elsener J. Genetic relatedness of recent Canadian equine influenza virus isolates with vaccine strains used in the field. Can. Vet. J. 2007, 48:1028-1030.
10. Gildea S., Quinlivan M., Arkins S., Cullinane A. The molecular epidemiology of equine influenza in Ireland from 2007-2010 and its international significance. Equine Vet. J. 2012, 44:387-392.
11. Guindon S., Delsuc F., Dufayard J.F., Gascuel O. Estimating maximum likelihood phylogenies with PhyML. Methods Mol. Biol. 2009, 537:113-137.
12. Ha Y., Stevens D.J., Skehel J.J., Wiley D.C. X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus. Virology 2003, 309:209-218.
13. Ito T., Kawaoka Y., Ohira M., Takakuwa H., Yasuda J., Kida H., Otsuki K. Replacement of internal protein genes, with the exception of the matrix, in equine 1 viruses by equine 2 influenza virus genes during evolution in nature. J. Vet. Med. Sci. 1999, 61:987-989.
14. Ito M., Nagai M., Hayakawa Y., Komae H., Murakami N., Yotsuya S., Asakura S., Sakoda Y., Kida H. Genetic analyses of an H3N8 influenza virus isolate, causative strain of the outbreak of equine influenza at the Kanazawa racecourse in Japan in 2007. J. Vet. Med. Sci. 2008, 70:899-906.
15. Khurana S., Wu J., Verma N., Verma S., Raghunandan R., Manischewitz J., King L., Kpamegan E., Pincus S., smith G., Glenn G., Golding H. H5N1 virus-like particle vaccine elicits cross-reactive neutralising antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. J. Virol. 2011, 85:10945-10954.
16. Johansson B.E., Matthews J.T., Kilbourne E.D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 1998, 16:1009-1015.
17. Lai A.C., Chambers T.M., Holland R.E., Morley P.S., Haines D.M., Townsend H.G., Barrandeguy M. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch. Virol. 2001, 146:1063-1074.
18. Lewis N.S., Daly J.M., Russell C.A., Horton D.L., Skepner E., Bryant N.A., Burke D.F., Rash A.S., Wood J.L., Chambers T.M., Fouchier R.A., Mumford J.A., Elton D.M., Smith D.J. Antigenic and genetic evolution of equine influenza A (H3N8) from 1968 to 2007. J. Virol. 2011, 85:12742-12749.
19. Lin Y.P., Gregory V., Collins P., Kloess J., Wharton S., Cattle N., Lackenby A., Daniels R., Hay A. Neuraminidase receptor binding variants of human influenza A (H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?. J. Virol. 2010, 84:6769-6781.
20. Lu Z., Chambers T.M., Boliar S., Timoney P.J., Branscum A.J., Reedy S.E., Tudor L., Dubovi E.J., Vickers M.L., Sells S., Balasuriya U.B.R. Development and evaluation of one-step Taqman® real-time reverse transcription-PCR assays targeting NP, M, and HA genes of equine influenza virus. J. Clin. Microbiol. 2009, 47:3907-3913.
21. Madić J., Martinović S., Naglić T., Hajsig D., Cvetnić S. Serological evidence for the presence of A/equine-1 influenza virus in unvaccinated horses in Croatia. Vet. Rec. 1996, 138:68.
22. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 2004, 78:12665-12667.
23. Murphy B.R., Kasel J.A., Chanock R.M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. N. Engl. J. Med. 1972, 286:1329-1332.
24. Newton J.R., Daly J.M., Spencer L., Mumford J.A. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet. Rec. 2006, 158:185-192.
25. OIE Equine influenza. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, 865-878. Office International des Epizooties, Paris, France.
26. OIE Expert surveillance panel on equine influenza vaccine composition - conclusions and recommendations. In Office International des Epizooties Bulletin 2008, 42-43.
27. OIE Expert surveillance panel on equine influenza vaccine composition - conclusions and recommendations. In Office International des Epizooties Bulletin 2010, 44-45.
28. OIE-WA interface., OIE-WAHID interface. World animal health information database, www.oie.int/wahis_2/public/wahid.php/Wahidhome/Home.
29. Pusterla N., Kass P.H., Mapes S., Johnson C., Barnett D.C., Vaala W., Gutierrez C., McDaniel R., Whitehead B., Manning J. Surveillance programme for important equine infectious respiratory pathogens in the USA. Vet. Rec. 2011, 169:12.
30. Russell R.J., Haire L.F., Stevens D.J., Collins P., Lin Y.P., Blackburn G.M., Hay A.J., Gamblin S.J., Skehel J.J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006, 443:45-49.
31. Seto J.T., Rott R. Functional significance of sialidase during influenza virus multiplication. Virology 1966, 30:731-737.
32. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
33. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., Fouchier R.A. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376.
34. Virmani N., Bera B.C., Singh B.K., Shanmugasundaram K., Gulati B.R., Barua S., Vaid R.K., Gupta A.K., Singh R.K. Equine influenza outbreak in India (2008-09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet. Microbiol. 2010, 143:224-237.
35. Webster R.G. Are equine 1 influenza viruses still present in horses?. Equine Vet. J. 1993, 25:537-538.
36. WHO: http://whqlibdoc.who.int/publications/2011/9789241548090_eng.pdf.
37. Yamanaka T., Niwa H., Tsujimura K., Kondo T., Matsumura T. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J. Vet. Med. Sci. 2008, 70:623-625.
38. Yates P., Mumford J.A. Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 2000, 74:173-177.